Keramed distribution rights
Ziemer Ophthalmic Systems AG has announced that it has obtained exclusive rights for distribution in Germany, Switzerland and Austria of the KeraKlear artificial cornea and the EndoInjector from Keramed Inc, Sunnyvale, California. The KeraKlear Artificial Cornea is a medical device for the treatment of corneal blindness which can be implanted in the eye through a very small incision. The EndoInjector (previously known as the EndoShield) is the latest generation device to enable delivery of a corneal graft for Descemet's Stripping Endothelial Keratoplasty (DSEK). 'The KeraKlear Artificial Cornea and EndoInjector have CE approval. No regulatory clearance is available for either product in the US. Market introduction of both products in Germany, Switzerland and Austria is scheduled for autumn 2012,' said a company spokeswoman. Â
Latest Articles
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Nutrition and the Eye: A Recipe for Success
A look at the evidence for tasty ways of lowering risks and improving ocular health.
New Award to Encourage Research into Sustainable Practices
Sharing a Vision for the Future
ESCRS leaders update Trieste conference on ESCRS initiatives.
Extending Depth of Satisfaction
The ESCRS Eye Journal Club discuss a new study reviewing the causes and management of dissatisfaction after implantation of an EDOF IOL.
Conventional Versus Laser-Assisted Cataract Surgery
Evidence favours conventional technique in most cases.
AI Scribing and Telephone Management
Automating note-taking and call centres could boost practice efficiency.